We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRSN icon
1126
VeriSign
VRSN
$26.5B
$5.3M 0.01%
44,732
+27,803
+164% +$3.22M
AAOI icon
1127
Applied Optoelectronics
AAOI
$11.2B
$5.29M 0.01%
211,104
+35,321
+20% +$1.1M
BH icon
1128
Biglari Holdings Class B
BH
$1.21B
$5.28M 0.01%
19,392
+6,325
+48% +$1.75M
JPST icon
1129
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
$5.28M 0.01%
+105,535
New +$5.28M
HQL
1130
abrdn Life Sciences Investors
HQL
$633M
$5.27M 0.01%
274,098
+27,080
+11% +$542K
ALV icon
1131
Autoliv
ALV
$8.92B
$5.25M 0.01%
49,908
+2,708
+6% +$279K
FXI icon
1132
iShares China Large-Cap ETF
FXI
$4.35B
$5.24M 0.01%
111,004
-33,913
-23% -$1.67M
PPH icon
1133
VanEck Pharmaceutical ETF
PPH
$1B
$5.24M 0.01%
92,275
+673
+0.7% +$40.2K
ABEV icon
1134
Ambev
ABEV
$45.4B
$5.24M 0.01%
720,864
-74,357
-9% -$511K
TDC icon
1135
Teradata
TDC
$2.58B
$5.24M 0.01%
132,113
+22,406
+20% +$882K
VISN
1136
Vistance Networks Inc
VISN
$2.63B
$5.22M 0.01%
130,500
-6,183
-5% -$241K
GHY
1137
PGIM Global High Yield Fund
GHY
$479M
$5.21M 0.01%
375,324
+194,407
+107% +$2.75M
JHML icon
1138
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
$5.19M 0.01%
150,175
+8,575
+6% +$304K
LAZ icon
1139
Lazard
LAZ
$4.16B
$5.18M 0.01%
98,489
+4,655
+5% +$258K
UNF icon
1140
Unifirst Corp
UNF
$5.24B
$5.15M 0.01%
31,879
+29,602
+1,300% +$4.75M
MEOH icon
1141
Methanex
MEOH
$4.27B
$5.15M 0.01%
84,856
+4,509
+6% +$265K
VVC
1142
DELISTED
Vectren Corporation
VVC
$5.14M 0.01%
80,486
+12,350
+18% +$764K
FUL icon
1143
H.B. Fuller
FUL
$3.29B
$5.14M 0.01%
103,428
+33,818
+49% +$1.75M
LNG icon
1144
Cheniere Energy
LNG
$54.9B
$5.14M 0.01%
96,202
+44,474
+86% +$2.45M
QYLD icon
1145
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.27B
$5.14M 0.01%
+215,821
New +$5.34M
FTNT icon
1146
Fortinet
FTNT
$120B
$5.13M 0.01%
479,210
-17,445
-4% -$170K
CPB icon
1147
Campbell Soup
CPB
$6.69B
$5.13M 0.01%
118,408
+70,929
+149% +$3.2M
DY icon
1148
Dycom Industries
DY
$12B
$5.11M 0.01%
47,496
+4,618
+11% +$524K
ILF icon
1149
iShares Latin America 40 ETF
ILF
$3.81B
$5.07M 0.01%
134,997
+124,095
+1,138% +$4.65M
LBRDA icon
1150
Liberty Broadband Class A
LBRDA
$5.17B
$5.07M 0.01%
59,816
+4,613
+8% +$413K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.